Bundamedik Tbk PT (BMHS) — Free Cash Flow Generation Index
Bundamedik Tbk PT (BMHS) has a Free Cash Flow Generation Index of 0.42x as of December 2025. Free cash flow of Rp83.38 Billion represents 0% of operating cash flow (Rp199.64 Billion). Explore Bundamedik Tbk PT (BMHS) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Bundamedik Tbk PT Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Bundamedik Tbk PT across 8 annual periods. For the full cash flow conversion analysis, see Bundamedik Tbk PT cash flow conversion.
Annual Free Cash Flow Generation for Bundamedik Tbk PT (2018–2025)
Year-by-year Free Cash Flow Generation Index for Bundamedik Tbk PT. Check Bundamedik Tbk PT (BMHS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (IDR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.13x | Rp31.72 Billion | Rp250.62 Billion | Rp218.91 Billion | ▲ +102.1% |
| 2024 | -5.95x | Rp-202.05 Billion | Rp33.98 Billion | Rp236.03 Billion | ▼ -93.7% |
| 2023 | -3.07x | Rp-157.91 Billion | Rp51.44 Billion | Rp209.35 Billion | ▼ -1034.5% |
| 2022 | -0.27x | Rp-64.26 Billion | Rp237.47 Billion | Rp301.73 Billion | ▼ -177.9% |
| 2021 | 0.35x | Rp121.36 Billion | Rp349.44 Billion | Rp228.08 Billion | ▼ -53.0% |
| 2020 | 0.74x | Rp140.75 Billion | Rp190.36 Billion | Rp49.61 Billion | ▲ +285.4% |
| 2019 | 0.19x | Rp17.21 Billion | Rp89.72 Billion | Rp72.50 Billion | ▲ +107.5% |
| 2018 | -2.57x | Rp-112.75 Billion | Rp43.79 Billion | Rp156.54 Billion | — |